These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation. Rizk OH; Teleb M; Abu-Serie MM; Shaaban OG Bioorg Chem; 2019 Nov; 92():103189. PubMed ID: 31473473 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors. El-Adl K; El-Helby AA; Sakr H; Elwan A Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414 [TBL] [Abstract][Full Text] [Related]
30. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Eissa IH; El-Helby AA; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; El-Adl K Bioorg Chem; 2020 Dec; 105():104380. PubMed ID: 33128967 [TBL] [Abstract][Full Text] [Related]
31. New quinoxalin-2(1H)-one-derived VEGFR-2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies. El-Adl K; Sakr HM; Yousef RG; Mehany ABM; Abulkhair HS; Eissa IH Arch Pharm (Weinheim); 2022 Jul; 355(7):e2200048. PubMed ID: 35437829 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors. El-Helby AA; Sakr H; Eissa IH; Abulkhair H; Al-Karmalawy AA; El-Adl K Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900113. PubMed ID: 31448458 [TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects. Elkaeed EB; Yousef RG; Elkady H; Gobaara IMM; Alsfouk BA; Husein DZ; Ibrahim IM; Metwaly AM; Eissa IH Molecules; 2022 Jul; 27(14):. PubMed ID: 35889478 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors. Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863 [TBL] [Abstract][Full Text] [Related]
35. Molecular Design and Synthesis of New 3,4-Dihydropyrimidin-2(1H)-Ones as Potential Anticancer Agents with VEGFR-2 Inhibiting Activity. Mostafa AS; Bayoumi WA; El-Mesery M; Elgaml A Anticancer Agents Med Chem; 2019; 19(3):310-322. PubMed ID: 30019649 [TBL] [Abstract][Full Text] [Related]